<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Research in Applied and Basic Medical Sciences</title>
<title_fa></title_fa>
<short_title>Journal of Research in Applied and Basic Medical Sciences</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijrabms.umsu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn></journal_id_issn>
<journal_id_issn_online>2717-0098</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/rabms</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>1</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Cetrorelix preserves follicular viability in Cyclophosphamid-induced ovarian toxicity</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>orginal article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Received 7 May 2015, accepted for publication 29 July 2015&lt;/strong&gt;&lt;/p&gt;

&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Background &amp; Aims: &lt;/strong&gt;Anticancer drugs are known to have great impact on spermatogenesis process and germinal epithelium. The present study is to investigate the preventive effect of Cetrorelix (GnRH antagonist) on Cyclophosphamide- induced spermatogenic defect.&lt;/p&gt;

&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Methods and Materials: &lt;/strong&gt;Fifty adult female mice aging 6-8 weeks (30&amp;plusmn;4 gr) were divided into 3 groups as: Control, Experimental 1 and Experimental 2. The animals in Experimental 1 group received Cyclophosphamide (2.5 mg/kg, ip) for 5 days and in Experimental 2 group received Cetrorelix (0.25 mg/kg, ip) one week before Cyclophosphamide treatment and continued for 3 weeks. The mice in all groups were sacrificed 35 days after the last injection. Ovarian follicles were isolated mechanically and the viability was studied by trypan blue staining.&lt;/p&gt;

&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Results: &lt;/strong&gt;Ovarian follicles of animals in Experimental 2group, retained higher percentage of normal morphology (P&lt;0.001) than which in Experimental 1 group and their condition were similar to control group.&lt;/p&gt;

&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;These results indicate that the Cetrorelix administration before cancer treatment may protect ovarian tissue against side effects of cisplatin.&lt;/p&gt;

&lt;p dir=&quot;ltr&quot;&gt;&lt;strong&gt;Keywords: &lt;/strong&gt;Ovarian follicles, Viability, GnRH antagonist, Cetrorelix&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Ovarian follicles, Viability, GnRH antagonist, Cetrorelix</keyword>
	<start_page>56</start_page>
	<end_page>60</end_page>
	<web_url>http://ijrabms.umsu.ac.ir/browse.php?a_code=A-10-55-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Daryosh</first_name>
	<middle_name></middle_name>
	<last_name>Mohammadnejad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abedelahia@yahoo.com</email>
	<code>1003194753284600255</code>
	<orcid>1003194753284600255</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamid</first_name>
	<middle_name></middle_name>
	<last_name>Tayefi-nasrabadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abedelahia@yahoo.com</email>
	<code>1003194753284600256</code>
	<orcid>1003194753284600256</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mehran</first_name>
	<middle_name></middle_name>
	<last_name>Naghibi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abedelahia@yahoo.coma</email>
	<code>1003194753284600257</code>
	<orcid>1003194753284600257</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Abedelahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abedelahia@yahoo.com</email>
	<code>1003194753284600258</code>
	<orcid>1003194753284600258</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Anatomical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
